| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/20/1997 | EP0789582A1 Glycosaminoglycan/megakaryocyte growth factor composition and therapeutical use thereof |
| 08/20/1997 | EP0789581A1 Method for the prevention and treatment of bovine mastitis |
| 08/20/1997 | EP0789580A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 08/20/1997 | EP0789579A1 Aza cyclohexapeptide compounds |
| 08/20/1997 | EP0789578A1 Multicatalytic protease inhibitors |
| 08/20/1997 | EP0789577A1 Synthesis of n-substituted oligomers |
| 08/20/1997 | EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789566A1 Hydroxyethyl aminimides |
| 08/20/1997 | EP0789561A1 Oral cyclosporin formulations |
| 08/20/1997 | EP0789553A1 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 08/20/1997 | EP0701571B1 Antibody fragments in therapy |
| 08/20/1997 | EP0670896A4 Cloning and expression of biologically active alpha-galactosidase a. |
| 08/20/1997 | EP0652892B1 Lactam dipeptides having hle inhibiting activity |
| 08/20/1997 | EP0644939A4 Protein kinase c (iota). |
| 08/20/1997 | EP0620737B1 Use of LACTOFERRIN iN the manufacture of a medicament for treating RHEUMATISM |
| 08/20/1997 | EP0593446B1 Monoclonal antibody which distinguishes helper inducer and supressor inducer cd4+ lymphocytes |
| 08/20/1997 | EP0586589B1 Amylin or amylin analogue composition optionally containing insulin for the treatment of anorexia and related states |
| 08/20/1997 | EP0487660B1 Treatment of thrombotic events |
| 08/20/1997 | CN1157621A Proinsulin peptide compound for detecting and treating type I diabetes |
| 08/20/1997 | CN1157620A Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 08/20/1997 | CN1157618A Novel substituted purinyl derivatives with immunomodulating activity |
| 08/20/1997 | CN1157571A Use of IL-4 for potentiation of chemotherapeutic agents |
| 08/20/1997 | CN1157570A Intracellular delivery of chemical agents to specific cell type |
| 08/20/1997 | CN1157566A Phosphonates and parathyroid hormone for osteoporosis |
| 08/20/1997 | CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 08/20/1997 | CN1157562A Sustained release preparation containing metal salt of peptide |
| 08/20/1997 | CN1157560A Implanted device containing tumor cells for treatment of cancer |
| 08/20/1997 | CN1157290A Recombinant obese (ob) proteins |
| 08/20/1997 | CA2197833A1 Pure somatostatin antagonist and methods of use thereof |
| 08/19/1997 | US5659061 Antitumor agents, enzyme inhibitors |
| 08/19/1997 | US5659045 Retroviral protease inhibiting compounds |
| 08/19/1997 | US5659044 Retroviral protease inhibiting compounds |
| 08/19/1997 | US5659018 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 08/19/1997 | US5659013 Vascular permeability factor targeted compounds |
| 08/19/1997 | US5658945 Anticancer agent; aids therapy; controlling infections |
| 08/19/1997 | US5658939 Prevention thrombosis in mammals |
| 08/19/1997 | US5658936 Administering dose of renin-angiotensin system inhibitor which modifies acutely systemic blood pressure by less than ten percent |
| 08/19/1997 | US5658935 Useful as inhibitors of thrombocyte aggregation, the metastasis of carcinoma cells and the binding of osteoclasts on bone surfaces |
| 08/19/1997 | US5658930 Thrombin inhibitors |
| 08/19/1997 | US5658908 Opioid diarylmethylpiperazines and piperdines |
| 08/19/1997 | US5658894 Polyanionic cyclodextrin derivative in carrier for promoting healing of wounded tissue |
| 08/19/1997 | US5658891 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 08/19/1997 | US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 08/19/1997 | US5658884 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 08/19/1997 | US5658883 Biologically active TGF-β1 peptides |
| 08/19/1997 | US5658882 Methods of inducting formation of tendon and/or ligament tissue comprising administering BMP-12, BMP-13, and/or MP-52 |
| 08/19/1997 | US5658879 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 08/19/1997 | US5658878 Therapeutic preparation for inhalation |
| 08/19/1997 | US5658877 Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein |
| 08/19/1997 | US5658876 Administering to patient a peptide of specific length, which after administering complexes with an activin receptor, capable of further complexing activin and inhibit release of follicle stimulating hormone |
| 08/19/1997 | US5658803 For diagnosis, prophylaxis, treatment of bacterial infections |
| 08/19/1997 | US5658792 Antiproliferative protein |
| 08/19/1997 | US5658788 Compounds and methods for treatment of thromboembolic disorders |
| 08/19/1997 | US5658786 DNA encoding rat taurine transporter and uses thereof |
| 08/19/1997 | US5658782 An isolated nucleic acid comprising a nucleotide sequence encoding a human excitatory amino acid transporter protein; genetic engineering |
| 08/19/1997 | US5658780 Rel a targeted ribozymes |
| 08/19/1997 | US5658776 Generation of high titers of recombinant AAV vectors |
| 08/19/1997 | US5658774 Inhibiting growth of tumor cells expressing oncogenes by introducing in vitro dna sequence encoding interferon regulatory factor, expressing said sequence |
| 08/19/1997 | US5658762 DNA molecules, expression vectors and host cells expressing antigenized antibodies |
| 08/19/1997 | US5658758 Human polypeptide |
| 08/19/1997 | US5658738 Bi-directional oligonucleotides that bind thrombin |
| 08/19/1997 | US5658729 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis |
| 08/19/1997 | US5658570 Includes an old world monkey portion and a human portion, nucleic acid encoding such antibodies |
| 08/19/1997 | US5658569 Anti-HIV-1 neutralizing antibodies |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | US5658567 Recombinant glycosylated biologically active human alpha-galactosidase a obtained by culturing host cell comprising recombinant baculovirus comprising nucleic acid encoding said enzyme, recovering |
| 08/19/1997 | US5658565 Encoding of protein by nucleic acid transferred to cells in vascular occlusion site; drug delivery |
| 08/19/1997 | US5658564 Xenograft thymus |
| 08/19/1997 | CA2118655C Parathyroid hormone-containing emulsion for nasal administration |
| 08/19/1997 | CA2020633C Mutant of pseudomonas, a strain yzh, and a process for producing 851 yzh nutrient solution by application of the strain |
| 08/19/1997 | CA1339339C Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 08/19/1997 | CA1339338C Composition and a process for inducing binding between parts of living mineralized tissue |
| 08/19/1997 | CA1339305C Production of human somatomedin c |
| 08/19/1997 | CA1339299C Human manganese superoxide dismutase dna; its expression; method of recovering human manganese superoxide dismutase, human manganese superoxide dismutase analogs or human manganese superoxide dismutase mutants; uses;compositions; and methods of treatment |
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
| 08/14/1997 | WO1997029201A2 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells |
| 08/14/1997 | WO1997029198A1 Thrombin muteins as antidotes for thrombin inhibitors |
| 08/14/1997 | WO1997029196A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | WO1997029192A1 Mammalian dendritic cell chemokine reagents |
| 08/14/1997 | WO1997029191A1 Chemotherapy resistance gene |
| 08/14/1997 | WO1997029189A1 Human neuronal attachment factor-1 |
| 08/14/1997 | WO1997029188A1 METHOD FOR THE PRODUCTION OF rDSPA α1 |
| 08/14/1997 | WO1997029185A1 Recombinant phages |
| 08/14/1997 | WO1997029184A1 Estrogen response element binding proteins and nucleotides encoding therefor |
| 08/14/1997 | WO1997029183A2 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | WO1997029182A1 Method and compositions for obtaining mature dendritic cells |
| 08/14/1997 | WO1997029180A1 Diabetes therapy |
| 08/14/1997 | WO1997029166A1 Antioxidant and process for producing the same |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029128A1 GPIb-LIPID COMPLEX AND USES THEREOF |
| 08/14/1997 | WO1997029121A1 Application of ureidoacetamides to the preparation of medicaments intended to the treatment of the abuse of drugs or substances giving rise to pharmacomania or to an excessive use |
| 08/14/1997 | WO1997029120A1 Sarcocystine isolation |
| 08/14/1997 | WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | WO1997028828A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 08/14/1997 | WO1997028826A2 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | WO1997028825A2 Spermatogenesis control |
| 08/14/1997 | WO1997028824A1 Obesity protein compounds and formulations thereof |
| 08/14/1997 | WO1997028821A1 Immunological methods for the treatment of gastrointestinal cancer |